Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
New York, NY
SEC filing record 1 source field available
Fiscal year end
31 December
SELLAS Life Sciences Group, Inc. has filed 1,267 SEC EDGAR filings since 07 Feb 2007

SEC filing history

Showing 551-575 of 1,000 matching filings.

Per page
25
Current page
23
3

GALENA BIOPHARMA, INC.

Filing date
10 Feb 2017
Reporting date
08 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
10 Feb 2017
Reporting date
08 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-84090

SC 13G/A

Filing date
10 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B5 File 333-208330

424B5

Filing date
09 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
07 Feb 2017
Reporting date
06 Feb 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-208330

424B2

Filing date
07 Feb 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
07 Feb 2017
Reporting date
14 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
31 Jan 2017
Reporting date
31 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-84090

SC 13G filing

Filing date
30 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2017
Reporting date
20 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2017
Reporting date
20 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2017
Reporting date
20 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2017
Reporting date
20 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2017
Reporting date
20 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2017
Reporting date
20 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
24 Jan 2017
Reporting date
20 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
19 Jan 2017
Reporting date
17 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-84090

SABBY 13G-A GALE 1.11.17

Filing date
11 Jan 2017
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
09 Jan 2017
Reporting date
09 Jan 2017
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
22 Dec 2016
Reporting date
22 Dec 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
20 Dec 2016
Reporting date
25 Oct 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-33958

8-K

Filing date
01 Dec 2016
Reporting date
29 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
15 Nov 2016
Reporting date
01 Nov 2016
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .